Chapter 6 - Use of magnetic resonance imaging and quantitative imaging reports in clinical care of multiple sclerosis

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F25%3A10494132" target="_blank" >RIV/00216208:11110/25:10494132 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/25:10494132

Výsledek na webu

<a href="https://doi.org/10.1016/B978-0-323-95739-7.00014-9" target="_blank" >https://doi.org/10.1016/B978-0-323-95739-7.00014-9</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/B978-0-323-95739-7.00014-9" target="_blank" >10.1016/B978-0-323-95739-7.00014-9</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Chapter 6 - Use of magnetic resonance imaging and quantitative imaging reports in clinical care of multiple sclerosis

Popis výsledku v původním jazyce

Magnetic resonance imaging (MRI) is the most established tool used for the diagnosis, prediction, and monitoring of disease activity and drug safety surveillance in multiple sclerosis (MS). The imaging hallmark of MS consists of focal demyelinated lesions within the brain and spinal cord. Neurodegeneration, as estimated by brain volume loss, is another important component of disease progression. Although MRI plays a central role in the diagnosis of MS, misinterpretation of MRI pathology is a frequent contributor to misdiagnosis. Given that only a small proportion of new MS lesions on MRI are symptomatic, monitoring patients with MS includes regular follow-up MRIs. Compared to clinical or biochemical measures, abnormal MRI findings are the most informative prognostic markers of future disease activity. Currently, platforms that provide quantitative MRI reports for clinical practice are available. However, there are some important pitfalls associated with assessing changes in brain volume.

Název v anglickém jazyce

Chapter 6 - Use of magnetic resonance imaging and quantitative imaging reports in clinical care of multiple sclerosis

Popis výsledku anglicky

Magnetic resonance imaging (MRI) is the most established tool used for the diagnosis, prediction, and monitoring of disease activity and drug safety surveillance in multiple sclerosis (MS). The imaging hallmark of MS consists of focal demyelinated lesions within the brain and spinal cord. Neurodegeneration, as estimated by brain volume loss, is another important component of disease progression. Although MRI plays a central role in the diagnosis of MS, misinterpretation of MRI pathology is a frequent contributor to misdiagnosis. Given that only a small proportion of new MS lesions on MRI are symptomatic, monitoring patients with MS includes regular follow-up MRIs. Compared to clinical or biochemical measures, abnormal MRI findings are the most informative prognostic markers of future disease activity. Currently, platforms that provide quantitative MRI reports for clinical practice are available. However, there are some important pitfalls associated with assessing changes in brain volume.

Druh

C - Kapitola v odborné knize

CEP obor

—

OECD FORD obor

30103 - Neurosciences (including psychophysiology)

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

Handbook of Imaging in Multiple Sclerosis

ISBN

978-0-323-95739-7

Počet stran výsledku

29

Strana od-do

93-121

Počet stran knihy

438

Název nakladatele

Academic Press

Místo vydání

London

Kód UT WoS kapitoly

—